ZBTB33
Basic information
Region (hg38): X:120250752-120258398
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZBTB33 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 31 | 34 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 31 | 4 | 4 |
Variants in ZBTB33
This is a list of pathogenic ClinVar variants found in the ZBTB33 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-120251791-G-A | Likely benign (May 01, 2023) | |||
X-120253449-A-C | not specified | Uncertain significance (Dec 03, 2024) | ||
X-120253452-C-G | not specified | Uncertain significance (Dec 05, 2016) | ||
X-120253468-T-G | not specified | Uncertain significance (Jul 02, 2024) | ||
X-120253520-C-T | Likely benign (Oct 01, 2022) | |||
X-120253578-A-G | not specified | Uncertain significance (Oct 17, 2023) | ||
X-120253804-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
X-120253873-A-G | not specified | Uncertain significance (Dec 28, 2023) | ||
X-120253960-A-G | not specified | Uncertain significance (Nov 26, 2024) | ||
X-120253979-T-TTGA | Benign (Jun 17, 2021) | |||
X-120254007-T-G | not specified | Uncertain significance (Jun 16, 2023) | ||
X-120254038-T-C | not specified | Uncertain significance (Jun 30, 2023) | ||
X-120254041-C-T | not specified | Uncertain significance (Dec 03, 2024) | ||
X-120254068-A-T | Uncertain significance (Jul 01, 2017) | |||
X-120254091-A-G | Benign (Aug 08, 2017) | |||
X-120254181-G-T | not specified | Uncertain significance (Oct 29, 2024) | ||
X-120254202-G-A | not specified | Uncertain significance (Oct 30, 2023) | ||
X-120254251-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
X-120254271-A-G | not specified | Likely benign (Jan 06, 2023) | ||
X-120254418-A-C | not specified | Uncertain significance (Sep 22, 2022) | ||
X-120254439-A-G | not specified | Uncertain significance (Dec 01, 2024) | ||
X-120254463-G-A | not specified | Uncertain significance (Jun 07, 2023) | ||
X-120254568-C-A | not specified | Uncertain significance (Sep 03, 2024) | ||
X-120254604-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
X-120254615-T-G | not specified | Uncertain significance (Oct 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZBTB33 | protein_coding | protein_coding | ENST00000326624 | 1 | 7647 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.913 | 0.0872 | 125696 | 0 | 5 | 125701 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.94 | 164 | 250 | 0.655 | 0.0000184 | 4426 |
Missense in Polyphen | 32 | 101.15 | 0.31635 | 1807 | ||
Synonymous | 1.76 | 73 | 94.9 | 0.770 | 0.00000721 | 1316 |
Loss of Function | 2.98 | 1 | 12.2 | 0.0817 | 8.43e-7 | 271 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000365 | 0.0000365 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000489 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator with bimodal DNA-binding specificity. Binds to methylated CpG dinucleotides in the consensus sequence 5'-CGCG-3' and also binds to the non-methylated consensus sequence 5'-CTGCNA-3' also known as the consensus kaiso binding site (KBS). Recruits the N-CoR repressor complex to promote histone deacetylation and the formation of repressive chromatin structures in target gene promoters. May contribute to the repression of target genes of the Wnt signaling pathway. May also activate transcription of a subset of target genes by the recruitment of CTNND2. Represses expression of MMP7 in conjunction with transcriptional corepressors CBFA2T3, CBFA2T2 and RUNX1T1 (PubMed:23251453). {ECO:0000269|PubMed:11445535, ECO:0000269|PubMed:14527417, ECO:0000269|PubMed:15548582, ECO:0000269|PubMed:15817151, ECO:0000269|PubMed:16354688, ECO:0000269|PubMed:23251453}.;
- Pathway
- Wnt Signaling Pathway and Pluripotency;Posttranslational regulation of adherens junction stability and dissassembly
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.283
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.21
Haploinsufficiency Scores
- pHI
- 0.645
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zbtb33
- Phenotype
- neoplasm; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;Wnt signaling pathway;intracellular signal transduction;negative regulation of transcription, DNA-templated
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytosol;plasma membrane
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;protein binding;methyl-CpG binding;sequence-specific DNA binding;metal ion binding